CN114945370A - 具有优异可生产性和溶出性的小尺寸片剂 - Google Patents

具有优异可生产性和溶出性的小尺寸片剂 Download PDF

Info

Publication number
CN114945370A
CN114945370A CN202080085661.2A CN202080085661A CN114945370A CN 114945370 A CN114945370 A CN 114945370A CN 202080085661 A CN202080085661 A CN 202080085661A CN 114945370 A CN114945370 A CN 114945370A
Authority
CN
China
Prior art keywords
weight
tablet
hydrochloride
less
hydroxypropyl cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080085661.2A
Other languages
English (en)
Chinese (zh)
Inventor
锭宽树
清水隆
西田阳平
松本太一
浅田拓海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of CN114945370A publication Critical patent/CN114945370A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Semiconductor Lasers (AREA)
CN202080085661.2A 2019-12-13 2020-12-11 具有优异可生产性和溶出性的小尺寸片剂 Pending CN114945370A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019225718 2019-12-13
JP2019-225718 2019-12-13
PCT/JP2020/046253 WO2021117861A1 (ja) 2019-12-13 2020-12-11 製造性及び溶出性に優れた小型錠剤

Publications (1)

Publication Number Publication Date
CN114945370A true CN114945370A (zh) 2022-08-26

Family

ID=76330003

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080085661.2A Pending CN114945370A (zh) 2019-12-13 2020-12-11 具有优异可生产性和溶出性的小尺寸片剂

Country Status (5)

Country Link
JP (2) JP7093473B2 (https=)
KR (1) KR20220113942A (https=)
CN (1) CN114945370A (https=)
TW (1) TW202135826A (https=)
WO (1) WO2021117861A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116440075A (zh) * 2023-06-01 2023-07-18 苏州中化药品工业有限公司 一种干混悬剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2896158B1 (fr) * 2006-01-13 2008-09-12 Merck Sante Soc Par Actions Si Combinaison de derives de triazine et d'inhibiteurs de la hmg-coa reductase.
FR2896157B1 (fr) * 2006-01-13 2008-09-12 Merck Sante Soc Par Actions Si Combinaison de derives de triazine et d'agents de stimulation de secretion d'insuline.
US8592370B2 (en) 2008-12-12 2013-11-26 Poxel S.A.S. Combination of insulin with triazine derivatives
TWI436768B (zh) 2010-06-09 2014-05-11 Poxel 第２型糖尿病之治療
KR20190120430A (ko) * 2012-01-06 2019-10-23 엘셀릭스 테라퓨틱스 인코포레이티드 바이구아나이드 조성물 및 대사 장애를 치료하는 방법
JP5775223B2 (ja) * 2012-09-05 2015-09-09 テイカ製薬株式会社 口腔内速崩壊性錠剤用造粒物
JPWO2017170858A1 (ja) * 2016-03-31 2019-02-14 インターセプト ファーマシューティカルズ， インコーポレイテッド 溶出性に優れた経口製剤
JP6854162B2 (ja) * 2017-03-17 2021-04-07 ライオン株式会社 錠剤
CA3103324A1 (en) * 2018-06-14 2019-12-19 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116440075A (zh) * 2023-06-01 2023-07-18 苏州中化药品工业有限公司 一种干混悬剂及其制备方法

Also Published As

Publication number Publication date
KR20220113942A (ko) 2022-08-17
JP2022123069A (ja) 2022-08-23
JPWO2021117861A1 (https=) 2021-06-17
TW202135826A (zh) 2021-10-01
WO2021117861A1 (ja) 2021-06-17
JP7671265B2 (ja) 2025-05-01
JP7093473B2 (ja) 2022-06-29

Similar Documents

Publication Publication Date Title
JP4868695B2 (ja) 崩壊性が良好な経口製剤
JP5794650B2 (ja) 難溶性薬物の溶解性改善製剤
EA029890B1 (ru) Фармацевтическая композиция и фармацевтическая композиция в пероральной дозированной лекарственной форме на основе ингибитора dpp iv
TWI405574B (zh) 藥學固體製劑及其製造方法
CN102688207A (zh) 新颖的药物组合物
JP7767651B2 (ja) Ｇｌｐ１医薬組成物
WO2001034147A1 (en) Oral solid preparation
CN113939289A (zh) 一种含有布鲁顿氏酪氨酸激酶抑制剂的口服固体片剂及其制备方法
TW200418457A (en) Oral solid form pharmaceutical and pharmaceutical for the treatment of dysuria
TWI419716B (zh) 奈韋拉平（ｎｅｖｉｒａｐｉｎｅ）之延長釋放調配劑
US20250325525A1 (en) Glp1 tablet compositions
TW201735928A (zh) 溶出性優異之口服製劑
WO2013114389A1 (en) Process for preparing solid oral formulations comprising low dose of entecavir
JP7671265B2 (ja) 製造性及び溶出性に優れた小型錠剤
EP3856162A1 (en) Pharmaceutical composition comprising vildagliptin and metformin and method of preparation thereof
HK40074201A (en) Small-sized tablet having excellent producibility and elution properties
CN112057427B (zh) 一种含有布鲁顿氏酪氨酸激酶抑制剂的口服固体片剂及其制备方法
JP5563371B2 (ja) クエチアピンフマル酸塩含有経口用錠剤
TW202435886A (zh) 米爾維仙(milvexian)醫藥組合物
JP6668666B2 (ja) イルベサルタンを含有する医薬組成物及びその製造方法
WO2025070617A1 (ja) 溶出性及び打錠性に優れた製剤
EA029709B1 (ru) Твердая пероральная лекарственная форма, содержащая декскетопрофен и трамадол, и способ ее изготовления
JP2014031359A (ja) バラシクロビル塩酸塩２型結晶を含有する錠剤とその製法
HK40047994B (zh) 含有难溶性碱性药剂的药物组合物
HK40000065A (en) Oral preparation having exceptional elutability

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40074201

Country of ref document: HK

SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination